Navigation Links
Following the Successful Launch in the United States, the New Simbionix U/S Mentor to be Introduced for the First Time in Europe
Date:6/11/2013

CLEVELAND, June 11, 2013 /PRNewswire/ --

Simbionix USA Corporation, a world leader of medical simulation training and products, will be exhibiting its new U/S Mentor™ Simulator for the first time in Europe at the upcoming SESAM (Society in Europe for Simulation Applied to Medicine) exhibition, in Paris, France.

     (Logo: http://photos.prnewswire.com/prnh/20120502/529202-a)

Ultrasound is widely used in medicine, as it is possible to perform both diagnosis and therapeutic procedures using ultrasound to guide interventional procedures. It is increasingly being used in trauma and first aid cases, with emergency ultrasound becoming a staple of most EMT response teams. Physicians and other healthcare professionals who provide direct patient care are using ultrasound in their office and hospital practices for efficient, low-cost, dynamic diagnostic imaging that facilitates treatment planning while avoiding any ionizing radiation exposure.

In correspondence with the rapidly growing utilization of ultrasound technology by various medical specialties, the Simbionix U/S Mentor provides a unique training opportunity, allowing healthcare professionals and clinical practitioners to independently acquire sonography skills in their field of practice. The innovative platform is comprised of a palpable mannequin and true-to-life simulated anatomies, physiology and pathologies, offering a selection of tasks and virtual patient cases for comprehensive training, incorporating didactics, real time guidance and captured metrics for objective assessment. Training modules incorporate ECG, image enhancement tools, measurements tools, color Doppler, cine-loops recording and clinical findings reporting, all supporting training to the full extent of the actual procedure.

"Developing the U/S Mentor follows the Simbionix mission to provide healthcare professionals with the most advanced training solutions," said Gary Zamler, Simbionix CEO. "This new simulator is the first in our line that is not intended only for MIS procedures, and addresses the current market needs and requests from our customers. The new U/S Mentor has been extremely well received in the United States, as clients were especially impressed with the realistic imaging and training options that it offers."

Stop by Simbionix booth #15 B+C at SESAM, June 13-15, in Paris, France, to experience the ground breaking U/S Mentor as well as our complete line of MIS simulators.

Simbionix USA Corporation is the world's leading provider of simulation, training and education products for medical professionals and the healthcare industry. The company is committed to delivering high quality products, advancing clinical performance and optimizing procedural outcomes.

Visit: http://www.simbionix.comFacebookTwitter and LinkedIn.

Contact: rebecca@simbionix.com
+1-216-2292040


'/>"/>
SOURCE Simbionix USA Corporation
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Ceregene Parkinsons Disease Study Demonstrates Long-term Neurturin Expression and Enhanced Dopamine Activity 4 Years Following Delivery of CERE-120 (AAV2-neurturin)
2. Anthera Updates Phase 3 Plans Following Results from the Phase 2b PEARL-SC Dose Ranging Study of Blisibimod
3. Ampio Advances NCE001 Cancer Drug into Preclinical Development Following Successful Recent Financing and the Granting of Patents in USA, Canada, Europe and China
4. Grifols Initiates Safety Study of Inhaled Alpha1-Proteinase Inhibitor (Human) Following Orphan Drug Designation for Cystic Fibrosis
5. Unigene Provides Update Following Recent EMA Recommendation on Calcitonin-Containing Medicines
6. Americas Interest in Obesity Surgery Soars Following its Success in Europe and ROW, Finds Frost & Sullivan
7. Coyote Pharmaceuticals Initiates GMP Manufacturing Process for CNS-102 Following Successful Pre-IND Meeting
8. Tarix Pharmaceuticals Peptide Technology Stimulates Revascularization Following Ischemia
9. invendo medical Announces US Market Entry Following Special 510(k) Clearance By FDA For Computer-Assisted Single-Use Colonoscopy System
10. Isis Pharmaceuticals Reports Clinical Data Showing Blunting of Severe Increases in CRP Following Endotoxin Challenge With ISIS-CRP Rx
11. Avanir Pharmaceuticals Announces Accelerated Development Path for AVP-786 Following Successful Pre-IND Meeting with FDA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... -- Eli Lilly and Company (NYSE: LLY ) today announced ... vitamin regimen patent would not presently be infringed by Actavis ... , Italy and Spain ... dextrose solution.  --> --> ... held that Lilly,s patent would be indirectly infringed by Actavis ...
(Date:2/12/2016)... , Feb. 12, 2016  Apellis ... completed a $47.1 million Series D preferred ... Asset Management, Hillhouse Capital Group and venBio ... Venture Investments, AJU IB Investment, and Epidarex ... used to further advance clinical trials in ...
(Date:2/11/2016)... 2016 The primary goal of this research ... on the usage of liquid biopsy. Key information the ... - Timeframe of liquid biopsy adoption amidst future users ... organization type - Sample inflow to conduct liquid biopsy ... serum, and so on. - Correlation analysis of sample ...
Breaking Medicine Technology:
(Date:2/12/2016)... ... February 12, 2016 , ... According to an article ... account for a significant portion of hernia repairs throughout the United States. Commenting on ... Hernia Center notes that this trend has not only been expected, but it seems ...
(Date:2/12/2016)... ... 12, 2016 , ... The law firm of Morrow, Morrow, Ryan & Bassett ... of these scholarships is to encourage applicants to pursue a degree in their field ... two parishes. , “We have available jobs in St. Landry and Evangeline Parishes ...
(Date:2/12/2016)... ... February 12, 2016 , ... The Lymphoma Research Foundation (LRF) ... and serving the lymphoma community through a comprehensive series of education programs, outreach ... community at its 10th anniversary Fashion Luncheon on Monday, February 8, 2016. The ...
(Date:2/12/2016)... ... February 12, 2016 , ... ... — 1:30 p.m. – 3:00 p.m. EST, http://www.fdanews.com/fixeddosecombination ... cycle of pharmaceutical products, garnering increased attention from all stakeholders in the development ...
(Date:2/12/2016)... ... 12, 2016 , ... As a former television executive, owner Tal Rabinowitz knows ... time to decompress, Rabinowitz found herself drawn to a casual meditation class while working ... her life, implementing a 20-minute-per-day meditation practice with her team. After her tenure at ...
Breaking Medicine News(10 mins):